Last quarter (Q2 2023), Cumberland Pharmaceuticals's total revenue was $10.89M, an increase of 5.73% from the same quarter last year. In Q2, Cumberland Pharmaceuticals's net income was $872.20K. See Cumberland Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 40.65M	$ 42.01M	$ 35.99M	$ 37.44M	$ 34.39M	$ 29.34M
Cost of Revenue	$ 2.35M	$ -9.12M	$ -8.81M	$ 8.65M	$ 7.42M	$ 6.02M
Gross Profit	$ 33.00M	$ 32.89M	$ 27.17M	$ 28.79M	$ 26.97M	$ 23.33M
Operating Expense	$ 38.09M	$ 39.01M	$ 36.26M	$ 35.17M	$ 36.26M	$ 34.50M
Operating Income	$ -5.09M	$ -6.12M	$ -9.09M	$ -6.38M	$ -9.29M	$ -11.17M
Net Non Operating Interest Income Expense	$ -533.24K	$ -487.59K	$ -71.95K	$ -188.28K	$ -2.82K	$ 368.64K
Other Income Expense	$ -2.83M	$ -47.90K	$ -2.93M	-	-	-
Pretax Income	$ -1.78M	$ -5.58M	$ -5.56M	$ -6.57M	$ -9.29M	$ -10.80M
Tax Provision	$ 68.92K	$ 68.85K	$ 34.89K	$ 55.90K	$ -79.32K	$ 16.64K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -2.80M	$ -6.55M	$ -4.18M	$ -3.34M	$ -3.54M	$ -6.96M
Basic EPS	$ -0.13	$ -0.38	$ -0.24	$ -0.22	$ -0.23	$ -0.45
Diluted EPS	$ -0.13	$ -0.38	$ -0.24	$ -0.22	$ -0.23	$ -0.45
Basic Average Shares	$ 57.79M	$ 14.56M	$ 14.90M	$ 15.16M	$ 15.40M	$ 15.61M
Diluted Average Shares	$ 58.18M	$ 14.56M	$ 14.90M	$ 15.16M	$ 15.40M	$ 15.61M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	$ 0.10	-	-	$ -0.01	$ 0.32	$ -0.03
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 40.44M	$ 29.89M	$ 27.45M	$ 43.82M	$ 43.68M	$ 40.52M
Net Income From Continuing And Discontinued Operation	$ -2.75M	$ -6.55M	$ -4.18M	$ -3.34M	$ -3.54M	$ -6.96M
Normalized Income	$ 277.94K	-	-	$ -6.55M	$ -9.20M	$ -10.75M
Interest Expense	$ 149.34K	-	-	$ 263.63K	$ 246.19K	$ 195.85K
EBIT	$ -1.12M	$ -5.00M	$ -5.46M	$ -6.31M	$ -9.04M	$ -10.61M
EBITDA	$ 3.35M	$ 344.16K	$ -823.78K	$ -1.56M	$ -4.64M	$ -7.63M

Currency in USD

Cumberland Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing